Peroxisome Proliferator-Activated Receptor Activity in Placental Development

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors that orchestrate lipid, glucose and amino acid metabolism during pregnancy and guide trophoblast differentiation, proliferation, migration and invasion. Three PPAR subtypes—PPARα, PPARβ/δ and PPARγ—form heterodimers with retinoid X receptors to regulate gene networks essential for the formation and function of the placental exchange interface. In early gestation, PPAR activity balances trophoblast proliferation against differentiation into syncytiotrophoblast and extravillous trophoblast lineages, thereby ensuring adequate uterine invasion, vascular remodelling and nutrient transfer. Dysregulation of PPAR signalling has been implicated in pregnancy disorders such as preeclampsia, intrauterine growth restriction and gestational diabetes, underpinning defective angiogenesis, inflammation and metabolic adaptation. Recent mechanistic studies have revealed cross-talk between PPARγ and inflammatory pathways, transcriptional control of key differentiation factors and stage-specific roles for PPARδ in maternal and embryonic compartments. Together, this body of work highlights the global significance of PPARs in placental health and offers a rationale for therapeutic modulation of receptor activity to prevent or ameliorate placentally mediated complications.

Research from Nature Portfolio

Recent studies have uncovered a novel axis linking PPARγ to nuclear factor-κB (NF-κB) in human first-trimester placental explants and trophoblast cell lines. Exposure to bacterial lipopolysaccharide elicits an inflammatory cascade that suppresses trophoblast differentiation markers and enhances apoptosis, while activation of PPARγ by the agonist rosiglitazone restores proliferation, reduces cytokine release and re-establishes expression of differentiation proteins. Concomitant inhibition of NF-κB signalling reverses inflammation-induced invasion defects, demonstrating that coordinated regulation by PPARγ and NF-κB is critical to maintain trophoblast function under inflammatory stress. This work illuminates a potential therapeutic pathway for targeting placental inflammation and abnormal differentiation in pregnancy disorders.

Peroxisome Proliferator-Activated Receptor Activity in Placental Development publication trend

The graph below shows the total number of articles in peroxisome proliferator-activated receptor activity in placental development across all publications each year (not limited to Nature Index journals).

Technical terms

Peroxisome proliferator-activated receptor (PPAR): A family of nuclear receptors (subtypes α, β/δ, γ) that regulate genes involved in lipid metabolism, energy homeostasis and cellular differentiation.

Trophoblast: The outer cell lineage of the early embryo that invades the uterine wall and differentiates into specialised subtypes comprising the placental exchange interface.

Syncytiotrophoblast: A multinucleated outer layer of trophoblast that mediates maternal–foetal nutrient and gas exchange.

Extravillous trophoblast: A subset of trophoblast cells that migrate into the decidua and remodel maternal spiral arteries to establish adequate blood flow.

GCM1 (glial cells missing-1): A transcription factor essential for syncytiotrophoblast differentiation and branching morphogenesis of the placental villous tree.

NF-κB (nuclear factor-κB): A transcription factor complex that regulates inflammatory and stress responses, intersecting with PPARγ to influence trophoblast survival and function.

References

1. The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia. Cells (2023).
2. Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion: Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia. Nutrients (2023).
3. Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions. International Journal of Molecular Sciences (2021).
4. PPARγ Regulates Trophoblast Proliferation and Promotes Labyrinthine Trilineage Differentiation. PLOS ONE (2009).
5. Rosiglitazone blocks first trimester in-vitro placental injury caused by NF-κB-mediated inflammation. Scientific Reports (2019).
6. Stage-specific Integration of Maternal and Embryonic Peroxisome Proliferator-activated Receptor δ Signaling Is Critical to Pregnancy Success*. Journal of Biological Chemistry (2007).